These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22647554)

  • 21. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis.
    Cohen SA; Gralnek IM; Ephrath H; Saripkin L; Meyers W; Sherrod O; Napier A; Gobin T
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):31-6. PubMed ID: 18607266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
    Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
    Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.
    Arai R
    Postgrad Med; 2010 Jul; 122(4):177-85. PubMed ID: 20675980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
    Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory evaluation of inflammatory bowel disease.
    Wong A; Bass D
    Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it time to re-classify Crohn's disease?
    Fedorak RN
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():99-106. PubMed ID: 15588801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic difficulties in inflammatory bowel disease pathology.
    Yantiss RK; Odze RD
    Histopathology; 2006 Jan; 48(2):116-32. PubMed ID: 16405661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of autoantibodies in inflammatory bowel disease.
    Herszényi L; Tulassay Z
    Dig Dis; 2012; 30(2):201-7. PubMed ID: 22722439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indeterminate colitis (nonspecific inflammatory bowel disease)].
    Micev M
    Acta Chir Iugosl; 2000; 47(1-2):31-42. PubMed ID: 10953364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Idiopathic inflammatory bowel disease--prediction and treatment].
    Lukás K
    Cas Lek Cesk; 2011; 150(6):315-20. PubMed ID: 21751503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
    Zissis M; Afroudakis A; Galanopoulos G; Palermos L; Boura X; Michopoulos S; Archimandritis A
    Am J Gastroenterol; 2001 Jul; 96(7):2177-83. PubMed ID: 11467650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prediction of the disease course in inflammatory bowel diseases].
    Kiss LS; Lakatos PL
    Orv Hetil; 2010 Feb; 151(8):293-301. PubMed ID: 20154000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
    Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.